Company / Operating Cash Flow
Bausch & Lomb Corp Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$283.0M
FY2025
5-year range
$232.0M / $873.0M
FY2021-FY2025
Trend
+22.0%
vs FY2024
Sector context
#71 of 164
Health Care
What the data says
At $283M, Bausch & Lomb Corp's operating cash flow ranks #71 of 164 in the Health Care sector. Operating Cash Flow has fluctuated over the past 6 years, ranging from $232M in FY2024 to $873M in FY2023.
Based on SEC 10-K filings.
$283M in FY2025 with a 5-year CAGR of -11.5%.
Declined from $873M to $283M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -6.4%
- 5-Year CAGR
- -11.5%
- 10-Year CAGR
- -
Sector benchmark
#71 of 164 in Health CareTop 43% of 164This company $283.0M Sector average $1.0B
▼
-72.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.5%, indicating a declining trend.
- In FY2025, operating cash flow increased 22.0% year-over-year.
- Ranks #71 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $283.0M | +22.0% |
| FY2024 | $232.0M | -73.4% |
| FY2023 | $873.0M | +153.0% |
| FY2022 | $345.0M | -60.5% |
| FY2021 | $873.0M | +67.2% |
| FY2020 | $522.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026